# CytomX Therapeutics, Inc.: Form 8-K, filed Feb 24, 2023

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2023-02-24
- Accepted by EDGAR: Feb 24, 2023, 07:00 ET
- Period: 2023-02-23
- Accession: 0001193125-23-047460
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312523047460/d414055d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312523047460/

## Items reported

- Item 4.02: Non-reliance on financial statements

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312523047460/d414055d8k.htm

Filed Feb 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-047460. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
